World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
21214
World Ranking
17209
National Ranking
568

Overview

François Doz is affiliated with Université Paris Cité in France and has a significant research presence in the field of medicine. Their work primarily revolves around cancer-related topics, with a focus on genetics, neurology, molecular biology, pulmonary and respiratory medicine, and oncology.

The researcher's publications span a range of main topics including glioma diagnosis and treatment, neuroblastoma research and treatments, childhood cancer survivors' quality of life, ocular oncology and treatments, lung cancer treatments and mutations, brain metastases and treatment, and cancer genomics and diagnostics.

Frequent co-authors collaborating with François Doz include:

  • Birgit Geoerger
  • Franck Bourdeaut
  • Theodore W. Laetsch
  • Christelle Dufour
  • Alexander Drilon

Publishing regularly in a number of prominent venues, François Doz has contributed many papers to:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Pediatric Blood & Cancer
  • European Journal of Cancer

Among the recent papers associated with François Doz are:

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials, 2020, The Lancet Oncology
  • Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors, 2021, Neuro-Oncology
  • Failure of human rhombic lip differentiation underlies medulloblastoma formation, 2022, Nature
  • A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression, 2021, Nature Communications
  • The transcriptional landscape of Shh medulloblastoma, 2021, Nature Communications

Best Publications

  • Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

    Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones

  • Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

    David S Hong;Steven G DuBois;Shivaani Kummar;Anna F Farago

  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Simon Bailey

  • Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution

    F Khelfaoui;P Validire;A Auperin;E Quintana

  • Cytogenetic Prognostication Within Medulloblastoma Subgroups

    David J.H. Shih;Paul A. Northcott;Marc Remke;Andrey Korshunov

  • Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial

    Birgitta Lannering;Stefan Rutkowski;Francois Doz;Barry Pizer

  • Postoperative Chemotherapy Without Irradiation for Ependymoma in Children Under 5 Years of Age: A Multicenter Trial of the French Society of Pediatric Oncology

    Jacques Grill;Marie-Cécile Le Deley;Danièle Gambarelli;Marie-Anne Raquin

  • Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

    Jean-Sébastien Guillamo;Alain Créange;Chantal Kalifa;Jacques Grill

  • Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children

    Jacques Grill;Christian Sainte-Rose;Anne Jouvet;Jean-Claude Gentet

  • A proposal for an international retinoblastoma staging system

    Guillermo Chantada;François Doz;Celia B.G. Antoneli;Richard Grundy

  • Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.

    Sarah Fattet;Sarah Fattet;Sarah Fattet;Christine Haberler;Christine Haberler;Christine Haberler;Patricia Legoix;Pascale Varlet

  • Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.

    Franck Bourdeaut;Delphine Lequin;Laurence Brugières;Stéphanie Reynaud

  • Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy—Results of the First French Prospective Study for the French Society of Pediatric Oncology

    Véronique Laithier;Jacques Grill;Marie-Cécile Le Deley;Marie-Madeleine Ruchoux

  • Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.

    Xavier Sastre;Guillermo L. Chantada;François Doz;Matthew W. Wilson;Matthew W. Wilson

  • Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma

    Sophie Postel-Vinay;Amélie S Véron;Franck Tirode;Gaelle Pierron

  • Temozolomide in Malignant Gliomas of Childhood: A United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

    Linda S Lashford;P Thiesse;A Jouvet;T Jaspan

  • TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

    Marc Remke;Vijaj Ramaswamy;John Peacock;David J.H. Shih

  • High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma : A SFOP and SFGM study

    F Namouni;F Doz;M.L Tanguy;E Quintana

Frequent Co-Authors

Gilles Vassal
Gilles Vassal Institut Gustave Roussy
Jacques Grill
Jacques Grill Institut Gustave Roussy
Olivier Delattre
Olivier Delattre PSL University
Stefan Rutkowski
Stefan Rutkowski Universität Hamburg
Jean Michon
Jean Michon Institute Curie
Eric Bouffet
Eric Bouffet University of Toronto
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Claude Houdayer
Claude Houdayer Centre Hospitalier Universitaire de Rouen
Steven C. Clifford
Steven C. Clifford Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine goes beyond becoming a doctor. There are a variety of online programs that open doors to healthcare careers, many of which offer flexibility for working adults and students with diverse backgrounds.

For example, online BSN programs for non nurses allow those without a prior nursing background to enter this rewarding field through accelerated learning. Similarly, students interested in administrative roles may benefit from a degree in healthcare administration, which prepares graduates for leadership and management positions in health organizations.

Not everyone wants to pursue patient care. If you prefer working behind the scenes, a career in medical coding and billing is a great option. Discover top medical billing and coding online schools that often provide financial aid and certification pathways. Additionally, there are nursing schools that don’t require TEAS or HESI testing, which can streamline the admissions process for aspiring nurses.

Each of these online degrees presents a unique career pathway, expanding options for those interested in healthcare professions within the USA.

Best Scientists Citing François Doz

Trending Scientists

Recently Published Articles